Some experts, lawmakers concerned about Hahn’s agenda as FDA commissioner

In an 18 to 5 vote earlier today, the Senate Health, Education, Labor and Pensions Committee sent the nomination of Stephen M. Hahn, MD, as the next FDA commissioner to the full Senate.Hahn, chief medical executive and professor of radiation oncology at the University of Texas MD Anderson Cancer Center, had pledged during a hearing before the committee last month to be impartial on all FDA matters, such as the lung injuries tied to vaping, the opioid epidemic and the drug approval process.“There are many issues that will come before the commissioner that are complex and engender honestRead More

Share on facebook
Share on twitter
Share on linkedin